Patent · US Expired

ISCOM or ISCOM-matrix comprising a mucous targetting substance and an antigen

US6607732B2 · kind B2 · utility

7Cited by

1References

12Claims

0Family size

Inventors

Bror Morein · Uppsala, SE
Karin Lovgren Bengtsson · Uppsala, SE
Jill Ekstrom · Alunda, SE

Key dates

Filing date	Aug 20, 1998
Grant date	Aug 19, 2003
Priority date	—
Expiry date	Aug 20, 2018

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/55577
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An immunogenic complex includes at least one glycoside and at least one lipid. The complex further contains a) at least one mucosal surface targeting protein, protein derivative or carbohydrate that targets lymphatic tissue and induces an immune response when administered locally on mucous membranes; and b) at least one passenger immunogen that lacks tropism for mucous membranes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.